Bundamedik Tbk PT (BMHS) — Cash Flow Quality Index
Bundamedik Tbk PT (BMHS) has a Cash Flow Quality Index of 1172.10x as of December 2025. Operating cash flow of Rp199.64 Billion exceeds net income of Rp170.33 Million, indicating high earnings quality where cash backs reported profits. Explore Bundamedik Tbk PT cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bundamedik Tbk PT Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Bundamedik Tbk PT across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Bundamedik Tbk PT investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Bundamedik Tbk PT (2018–2025)
Year-by-year earnings quality comparison for Bundamedik Tbk PT. For live market cap and the full company financial profile, see how much is Bundamedik Tbk PT worth.
| Year | Quality Index | Operating CF (IDR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 20.18x | Rp250.62 Billion | Rp12.42 Billion | ▲ +609.3% |
| 2024 | 2.85x | Rp33.98 Billion | Rp11.94 Billion | ▼ -58.7% |
| 2023 | 6.89x | Rp51.44 Billion | Rp7.46 Billion | ▲ +274.3% |
| 2022 | 1.84x | Rp237.47 Billion | Rp128.93 Billion | ▲ +13.1% |
| 2021 | 1.63x | Rp349.44 Billion | Rp214.49 Billion | ▼ -24.0% |
| 2020 | 2.14x | Rp190.36 Billion | Rp88.79 Billion | ▼ -52.5% |
| 2019 | 4.51x | Rp89.72 Billion | Rp19.89 Billion | ▼ -47.2% |
| 2018 | 8.54x | Rp43.79 Billion | Rp5.13 Billion | — |